502 results on '"Blanck, O"'
Search Results
2. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)
3. Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)
4. Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose
5. Mid-term outcomes after stereotactic arrhythmia radioablation for refractory ventricular tachycardia
6. Stereotactic arrhythmia radioablation for refractory ventricular tachycardia. A retrospective analysis and optimisation of the planning phase
7. Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma—a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology
8. Stereotactic body radiotherapy (SBRT) for multiple pulmonary oligometastases: Analysis of number and timing of repeat SBRT as impact factors on treatment safety and efficacy
9. STEREOTACTIC ARRHYTHMIA RADIOABLATION IN EUROPE: THE ITALIAN SITUATION IN THE TREATMENT PLANNING BENCHMARK OF THE STOPSTORM CONSORTIUM
10. Radiation Necrosis following SRS or FSRT with Higher BED for Brain Metastases >20 mm
11. What MRI Sequences are Necessary for Automated Neural Network-Based Metastasis Segmentation ― An Ablation Study
12. Post-Operative Stereotactic Radiotherapy for Resected Brain Metastases: Results of the Multicenter Analysis (AURORA) of the German Working Group "Stereotactic Radiotherapy"
13. Stereotactic body radiotherapy for oligo-metastatic liver disease – Influence of pre-treatment chemotherapy and histology on local tumor control
14. Nomogram based overall survival prediction in stereotactic body radiotherapy for oligo-metastatic lung disease
15. P09-11: Towards a qAOP to predict thyroid disruption linked to neurodevelopmental toxicity in rats
16. STereotactic Arrhythmia Radioablation (STAR): the Standardized Treatment and Outcome Platform for Stereotactic Therapy Of Re-entrant tachycardia by a Multidisciplinary consortium (STOPSTORM.eu) and review of current patterns of STAR practice in Europe
17. Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO) (vol 198, pg 919, 2022)
18. Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
19. Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)
20. Reproducible target transfer from electroanatomic mapping to radiotherapy planning systems for cardiac radioablation - cross-validation for the RAVENTA trial
21. Stereotactic Arrhythmia Radioablation (STAR) for refractory ventricular tachycardia (VT) - A preliminary report from the German multicenter RAVENTA study
22. OC-0940 Assessment of cardiorespiratory motion for cardiac radioablation using a digital 17-segment model
23. PO-1701 STereotactic Arrhythmia Radioablation in Europe–Treatment Unit QA Audit of the STOPSTORM Consortium
24. OC-0620 Simultaneously Integrated Protection in SBRT of Pancreas - An International Planning Benchmark Study
25. PD-0174 Radiomics-based prediction of local control of brain metastases after resection and radiotherapy
26. OC-0941 STereotactic Arrhythmia Radioablation in Europe: STOPSTORM Consortium Treatment Planning Benchmark
27. PD-0064 Metastases-directed SRT combined with systemic therapy: 2y results of the TOaSTT real-world database
28. MO-04.12 - STEREOTACTIC ARRHYTHMIA RADIOABLATION IN EUROPE: THE ITALIAN SITUATION IN THE TREATMENT PLANNING BENCHMARK OF THE STOPSTORM CONSORTIUM
29. Interobserver agreement on definition of the target volume in stereotactic radiotherapy for pancreatic adenocarcinoma using different imaging modalities
30. Thyroid tumor formation in the male mouse induced by fluopyram is mediated by activation of hepatic CAR/PXR nuclear receptors
31. Sequential Optimization Scripts to Facilitate Treatment Planning for Robotic Radiosurgery Clinical Studies for Prostate and Lung Cancers
32. Evaluation of the Clinical Utility of an IrisTM Collimator Combined with a Sequential Optimization Algorithm for Robotic Radiosurgery
33. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases
34. Correction to: Stereotactic radiosurgery and radiotherapy for resected brain metastases: current pattern of care in the Radiosurgery and Stereotactic Radiotherapy Working Group of the German Association for Radiation Oncology (DEGRO)
35. Stereotactic Arrhythmia Radioablation in Europe—Treatment Planning Benchmark Results of the STOPSTORM.eu Consortium
36. STereotactic Arrhythmia Radioablation: Critical Structure Contouring Benchmark Results of STOPSTORM
37. A step towards routine for stereotactic radioablation in refractory ventricular tachycardia – interim analysis on short term safety of the first prospective, multi-centre, multi-platform study RAVENTA
38. The screening of everyday life chemicals in validated assays targeting the pituitary–gonadal axis
39. The SBRT database initiative of the German Society for Radiation Oncology (DEGRO): patterns of care and outcome analysis of stereotactic body radiotherapy (SBRT) for liver oligometastases in 474 patients with 623 metastases
40. Stereotactic arrhythmia radioablation in europe: treatment planning benchmark results of the STOPSTORM consortium
41. STereotactic Arrhythmia Radioablation in Europe: critical structure contouring benchmark results of the STOPSTORM Consortium
42. Survey results of the STOPSTORM consortium about stereotactic arrhythmia radioablation in Europe
43. PO-1065 STereotactic Arrhythmia Radioablation (STAR) in Europe – Survey Results of the STOPSTORM Consortium
44. Improving interinstitutional and intertechnology consistency of pulmonary SBRT by dose prescription to the mean internal target volume dose
45. Toxicity of SRT combined with targeted agents: prospective analysis of the TOaSTT database
46. Combining computed tomography and biologically effective dose radiomics improves prediction of tumor response to robotic lung SBRT
47. Long-Term Characterization of MRI-Morphologic Alterations After Active Motion-Compensated Liver SBRT
48. Toxicity of stereotactic Radiotherapy in Combination with targeted System Therapies: prospective Analysis of the TOaSTT Database
49. OC-0474: Feasibility of prostate SBRT with DIL boost in various platforms: A Crowd Knowledge based study
50. Radiosurgery beyond cancer: Real-time target localisation and treatment planning for cardiac radiosurgery under MRI guidance
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.